Menopause and premature ovarian insufficiency in rheumatic diseases: A review

Premature ovarian insufficiency (POI) is a clinical syndrome defined as loss of ovarian function before the age of 40 years. Among the causes of POI are genetic, metabolic disorders, as well as infectious or iatrogenic factors, but in some cases the exact cause cannot be established. Given the possi...

Full description

Bibliographic Details
Main Authors: Taras S. Panevin, Antonina V. Ledina, Evgeniy G. Zotkin
Format: Article
Language:Russian
Published: IP Berlin A.V. 2023-12-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/340799/pdf
_version_ 1827345606847234048
author Taras S. Panevin
Antonina V. Ledina
Evgeniy G. Zotkin
author_facet Taras S. Panevin
Antonina V. Ledina
Evgeniy G. Zotkin
author_sort Taras S. Panevin
collection DOAJ
description Premature ovarian insufficiency (POI) is a clinical syndrome defined as loss of ovarian function before the age of 40 years. Among the causes of POI are genetic, metabolic disorders, as well as infectious or iatrogenic factors, but in some cases the exact cause cannot be established. Given the possible association of ovarian failure with autoimmune disorders, as well as the detection of antibodies to normal ovarian tissue in the serum of patients with POI, it is assumed that an autoimmune mechanism is a significant cause of the syndrome. Taking into account the relationship between POI and autoimmune diseases, it seems relevant to address the issues of mutual influence of the ovarian function of women with POI and rheumatic diseases (in particular, systemic lupus erythematosus, rheumatoid arthritis and systemic scleroderma), which is presented in this review. Hormone replacement therapy may be recommended for women with POI to improve their quality of life. Keywords: premature ovarian insufficiency, menopause, anti-ovarian antibodies, systemic lupus erythematosus, rheumatoid arthritis, systemic scleroderma, rheumatic diseases, hormone replacement therapy.
first_indexed 2024-03-07T23:15:01Z
format Article
id doaj.art-5d7fcdb3f375442e84f3de59019624bb
institution Directory Open Access Journal
issn 2079-5696
2079-5831
language Russian
last_indexed 2024-03-07T23:15:01Z
publishDate 2023-12-01
publisher IP Berlin A.V.
record_format Article
series Гинекология
spelling doaj.art-5d7fcdb3f375442e84f3de59019624bb2024-02-21T13:58:58ZrusIP Berlin A.V.Гинекология2079-56962079-58312023-12-0125442843410.26442/20795696.2023.4.20236679551Menopause and premature ovarian insufficiency in rheumatic diseases: A reviewTaras S. Panevin0https://orcid.org/0000-0002-5290-156XAntonina V. Ledina1https://orcid.org/0000-0001-6354-0475Evgeniy G. Zotkin2https://orcid.org/0000-0002-4579-2836Nasonova Research Institute of RheumatologyPeople’s Friendship University of Russia (RUDN University)Nasonova Research Institute of RheumatologyPremature ovarian insufficiency (POI) is a clinical syndrome defined as loss of ovarian function before the age of 40 years. Among the causes of POI are genetic, metabolic disorders, as well as infectious or iatrogenic factors, but in some cases the exact cause cannot be established. Given the possible association of ovarian failure with autoimmune disorders, as well as the detection of antibodies to normal ovarian tissue in the serum of patients with POI, it is assumed that an autoimmune mechanism is a significant cause of the syndrome. Taking into account the relationship between POI and autoimmune diseases, it seems relevant to address the issues of mutual influence of the ovarian function of women with POI and rheumatic diseases (in particular, systemic lupus erythematosus, rheumatoid arthritis and systemic scleroderma), which is presented in this review. Hormone replacement therapy may be recommended for women with POI to improve their quality of life. Keywords: premature ovarian insufficiency, menopause, anti-ovarian antibodies, systemic lupus erythematosus, rheumatoid arthritis, systemic scleroderma, rheumatic diseases, hormone replacement therapy.https://gynecology.orscience.ru/2079-5831/article/viewFile/340799/pdfpremature ovarian insufficiencymenopauseanti-ovarian antibodiessystemic lupus erythematosusrheumatoid arthritissystemic sclerodermarheumatic diseaseshormone replacement therapy
spellingShingle Taras S. Panevin
Antonina V. Ledina
Evgeniy G. Zotkin
Menopause and premature ovarian insufficiency in rheumatic diseases: A review
Гинекология
premature ovarian insufficiency
menopause
anti-ovarian antibodies
systemic lupus erythematosus
rheumatoid arthritis
systemic scleroderma
rheumatic diseases
hormone replacement therapy
title Menopause and premature ovarian insufficiency in rheumatic diseases: A review
title_full Menopause and premature ovarian insufficiency in rheumatic diseases: A review
title_fullStr Menopause and premature ovarian insufficiency in rheumatic diseases: A review
title_full_unstemmed Menopause and premature ovarian insufficiency in rheumatic diseases: A review
title_short Menopause and premature ovarian insufficiency in rheumatic diseases: A review
title_sort menopause and premature ovarian insufficiency in rheumatic diseases a review
topic premature ovarian insufficiency
menopause
anti-ovarian antibodies
systemic lupus erythematosus
rheumatoid arthritis
systemic scleroderma
rheumatic diseases
hormone replacement therapy
url https://gynecology.orscience.ru/2079-5831/article/viewFile/340799/pdf
work_keys_str_mv AT tarasspanevin menopauseandprematureovarianinsufficiencyinrheumaticdiseasesareview
AT antoninavledina menopauseandprematureovarianinsufficiencyinrheumaticdiseasesareview
AT evgeniygzotkin menopauseandprematureovarianinsufficiencyinrheumaticdiseasesareview